On Oct 09, major Wall Street analysts update their ratings for $Accolade (ACCD.US)$, with price targets ranging from $5 to $9.
Morgan Stanley analyst Craig Hettenbach maintains with a hold rating, and maintains the target price at $6.
BofA Securities analyst Allen Lutz maintains with a buy rating, and adjusts the target price from $7 to $5.75.
Barclays analyst Stephanie Davis maintains with a hold rating, and maintains the target price at $5.
Needham analyst Ryan MacDonald maintains with a buy rating, and maintains the target price at $8.
BTIG analyst David Larsen maintains with a hold rating.
Furthermore, according to the comprehensive report, the opinions of $Accolade (ACCD.US)$'s main analysts recently are as follows:
The second quarter results for Accolade reiterated existing themes within the company, such as enhanced profitability in conjunction with moderated revenue growth. Revised forecasts for FY25 revenue and adjusted EBITDA have been issued post-report, with reductions reflecting diminished growth in PlushCare and across the broader business model, subsequently influencing EBITDA projections.
Post the fiscal Q2 report, there has been a rally in shares due to a 'solid print,' with the company maintaining its fiscal 2025 guidance, optimistic commentary about the selling season, and significant visibility into a 'steeper-than-usual' Q4 ramp. There appears to be a challenging near-term environment for securing new employer wins; however, the shift towards a 'honed focus on profitable growth' is seen in a positive light.
Here are the latest investment ratings and price targets for $Accolade (ACCD.US)$ from 8 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間10月9日，多家華爾街大行更新了$Accolade (ACCD.US)$的評級，目標價介於5美元至9美元。
摩根士丹利分析師Craig Hettenbach維持持有評級，維持目標價6美元。
美銀證券分析師Allen Lutz維持買入評級，並將目標價從7美元下調至5.75美元。
巴克萊銀行分析師Stephanie Davis維持持有評級，維持目標價5美元。
Needham分析師Ryan MacDonald維持買入評級，維持目標價8美元。
BTIG分析師David Larsen維持持有評級。
此外，綜合報道，$Accolade (ACCD.US)$近期主要分析師觀點如下：
Accolade第二季度的業績重申了公司內部的現有主題，如提高的盈利能力以及適度的營業收入增長。已經發布了對FY25營業收入和調整後的EBITDA的修訂預測報告，其中包括PlushCare以及整體業務模式增長減緩所反映出的減少，隨後影響了EBITDA預測。
發帖財政Q2報告後，由於「良好表現」，股價出現了上漲，公司保持了其2025財年的指引，對銷售季節發表了樂觀評論，並對「比平時更陡」的Q4增長提供了重要的見解。在爭取新僱主勝利方面似乎存在着具有挑戰性的短期環境；然而，向「專注於盈利增長」的轉變被積極看待。
以下爲今日8位分析師對$Accolade (ACCD.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
